With over 6000 L of fermentation capacity, Mycodev Group has built a state-of-the-art facility in Canada to produce excipient grade chitosan.
While other chitosan producers rely on waste materials for their production (waste shellfish or mushroom), Mycodev only uses fungus from our pharmaceutical-like fermentation process. This provides a highly traceable and consistent chitosan.
From start to finish, the entire process is strictly controlled and adheres to GMP (Good Manufacturing Practices) guidelines for pharmaceutical excipients.